>
VC FIRMS
>
Logos Capital
Logos Capital venture capital firm logo

Logos Capital

Founded:
2019
Investments:
86
Exits:
45

About Logos Capital

Logos Capital is a fundamental biotechnology-focused investment fund.

Portfolio companies:
Parse Biosciences,Gennao Bio,Odyssey Therapeutics
Fund type:
Venture Fund
Investment stage:
Series C
Series D
Series B
Investment focus:
BioTech
HQ-Country:
United States
City:
San Francisco
Go to website

BioTech

San Francisco

Series C

Series D

Series B

United States

Industries
Stages
Countries
Cities
Explore
Find investors on Gilion
Industries
Apps
AI
BioTech
E-Commerce
FinTech
Software
SaaS
MarTech
LegalTech
Stages
Early Stage
Pre-Seed
Seed
Series A
Series B
Countries
Denmark
Finland
France
Germany
Sweden
United Kingdom
United States
Cities
Amsterdam
Berlin
Copenhagen
London
Los Angeles
Miami
Munich
New York
Paris
San Francisco
Seattle
Silicon Valley
Stockholm